Month: May 2022

Revenue increased 28% to $8.7 million in Q1 2022 vs. $6.8 million in Q1 2021 Net income from continuing operations of $2.0 million in Q1 2022 vs. $0.4 million in Q1 2021 Adjusted EBITDA increased $1.0 million to $1.6 million in Q1 2022 vs. $0.6 million in Q1 2021RESTON, Va., May 16, 2022 (GLOBE NEWSWIRE) — Comstock Holding Companies, Inc. (Nasdaq: CHCI) (“Comstock” or the “Company”) announced financial results for the three months ended March 31, 2022. “Our first quarter performance continues our trend of delivering positive results, demonstrating the strength of our Anchor Portfolio and reliability of our vertically-integrated operating and investment platform,” said Christopher Clemente, Comstock’s Chairman and Chief Executive Officer. “First quarter highlights include the further expansion of our BLVD-branded residential...

MONTREAL, May 16, 2022 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a high-tech company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG), is pleased to announce today its financial and operational results for the first quarter ended March 31st, 2022. “We are happy to be announcing our Q1 2022 financial results. We have posted quarterly revenues of $4.2MM,” said Mr. P. Peter Pascali, CEO and Chair of PyroGenesis. “Our backlog remains very large, above $41MM, and despite gross reported revenue being impacted this quarter slightly by accounting procedures related to international logistical and shipping challenges,...

First Quarter 2022 Financial Results Maintain Growth Trends NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES30% increase in revenue over the same period last year, driven by higher patient volumes and the acquisitions of Khure Health and Polyclinic in 2021. Quarterly revenue of $13.0 million, on track for another record year in multiple business units. Patient volumes up 12% over the same period last year, excluding increases from acquisitions. Doubling of specialist visits through in-network care pathway optimization and significant advancement in both the rollout of the Company’s smart referral system that leverages the Company’s new data backbone and standing-up the Company’s data lake to support customers seeking access to analytic insights contained in the Company’s 2.9 million health records,...

Second Fiscal Quarter HighlightsInitial Public Offering: The Company completed its Initial Public Offering (IPO) and began trading on the Nasdaq Global Select Market under the symbol HNVR on May 11, 2022. Gross proceeds of $26.8 million were raised at an offering price of $21.00 per share. Net Income: Net income for the quarter ended March 31, 2022, totaled $5.9 million or $1.00 per diluted common share, versus $2.1 million or $0.48 per diluted common share in the same period a year ago. The Company recorded net income for the six months ended March 31, 2022 of $12.4 million or $2.15 per diluted common share compared to $3.6 million or $0.84 per diluted common share in the comparable 2021 six-month period. Initiation of Quarterly Cash Dividend: The Company’s Board of Directors approved a $0.10 per common share cash dividend paid on February 15,...

MONTREAL, May 16, 2022 (GLOBE NEWSWIRE) — NanoXplore Inc. (“NanoXplore” or “the Company”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, reported today financial results for the third quarter ended March 31, 2022. HIGHLIGHTSRecord revenues from customers of $28.0 million in Q3-2022, up 51.9% compared to Q2-2022 Increased graphene sales including sales to Gerdau Grafeno LTDA Adjusted EBITDA* totaled -$2.2 million in Q3-2022, an improvement from the -$3.1 million in Q2-2022. On target for positive Adjusted EBITDA for Q4-2022 Total Liquidity of $62.9 million as of March 31, 2022, including cash and cash equivalents of $56.1 million Total long-term debt of $9.7 million as of March 31, 2022 Increased sales guidance to $90 million versus previously announced $85 million for the current fiscal year ending June 30, 2022OVERVIEW Soroush...

Posts Revenue Growth of 38% and Adjusted EBITDA Growth of 31% Reiterates Outlook for Calendar Year End 2022 CINCINNATI, May 16, 2022 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced its second quarter fiscal 2022 financial results and operational highlights. These results pertain to the three-month period ended March 31, 2022 and are reported in U.S. Dollars. Financial Highlights:Revenue for Q2 2022 was $33.6 million compared to $24.2 million for Q2 2021, representing a 38% increase in revenue year-over-year. Compared to Q1 2022, the Company experienced sequential organic growth of 2%.As of March 31, 2022, the Company’s backlog decreased to approximately 6,500 patients in the...

MINNEAPOLIS, May 16, 2022 (GLOBE NEWSWIRE) — Autoscope Technologies Corporation (Nasdaq: AATC) today announced results for its quarter ended March 31, 2022. First Quarter 2022 Financial SummaryFirst quarter royalties remained constant at $1.8 million compared the same period in the prior year. First quarter product sales were $934,000, a decrease of 20 percent from the same period in the prior year. Operating expenses totaled $2.1 million in the first quarter of 2022, an increase of 14 percent from the prior year period. Net income for the first quarter of 2022 totaled $17,000, a decrease of approximately $1.0 million when compared to a net income of $1.1 million for the same period in the prior year, due to the forgiveness of the Payroll Protection Loan.First-Quarter Results: First quarter 2022 revenue for Autoscope Technologies...